Is your relationship with you doc face to face or you use telemedicine?
Defy sent this out today;
The DEA has proposed new rules to update the Ryan Haight Act, which could negatively affect telemedicine prescribing of non-narcotic medications in Schedules III, IV, and V. Testosterone is considered a Schedule III medication.
These rules would require in-person evaluations (physical exams), stricter record-keeping, increased coordination between physicians, and more frequent smaller refills. If approved, the update would go into effect after the current DEA waiver of the in-person exam requirement expires on May 11, 2023.
This could create unnecessary burdens for both patients and doctors, leading to limited access to treatment and increased risk of harm to patients.